Literature DB >> 22210266

Hospital-acquired Clostridium difficile infection: determinants for severe disease.

J M Wenisch1, D Schmid, H-W Kuo, E Simons, F Allerberger, V Michl, P Tesik, G Tucek, C Wenisch.   

Abstract

Risk factors of severity (need for surgical intervention, intensive care or fatal outcome) were analysed in hospital-acquired Clostridium difficile infection (CDI) in a 777-bed community hospital. In a prospective analytical cross-sectional study, age (≥ 65 years), sex, CDI characteristics, underlying diseases, severity of comorbidity and PCR ribotypes were tested for associations with severe CDI. In total, 133 cases of hospital-acquired CDI (mean age 74.4 years) were identified, resulting in an incidence rate of 5.7/10,000 hospital-days. A recurrent episode of diarrhoea occurred in 25 cases (18.8%) and complications including toxic megacolon, dehydration and septicaemia in 69 cases (51.9%). Four cases (3.0%) required ICU admission, one case (0.8%) surgical intervention and 22 cases (16.5%) died within the 30-day follow-up period. Variables identified to be independently associated with severe CDI were severe diarrhoea (odds ratio [OR] 3.64, 95% confidence interval [CI] 1.19-11.11, p=0.02), chronic pulmonary disease (OR 3.0, 95% CI 1.08-8.40, p=0.04), chronic renal disease (OR 2.9, 95% CI 1.07-7.81, p=0.04) and diabetes mellitus (OR 4.30, 95% CI 1.57-11.76, p=0.004). The case fatality of 16.5% underlines the importance of increased efforts in CDI prevention, in particular for patients with underlying diseases.

Entities:  

Mesh:

Year:  2011        PMID: 22210266     DOI: 10.1007/s10096-011-1522-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  43 in total

1.  Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008.

Authors:  A P McGowan; L C Lalayiannis; J B Sarma; B Marshall; K E Martin; M R Welfare
Journal:  J Hosp Infect       Date:  2010-12-03       Impact factor: 3.926

2.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

4.  Chronic kidney disease and risk of death from infection.

Authors:  Henry E Wang; Christopher Gamboa; David G Warnock; Paul Muntner
Journal:  Am J Nephrol       Date:  2011-08-22       Impact factor: 3.754

5.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Authors:  Frédéric Barbut; Dominique Decré; Valérie Lalande; Béatrice Burghoffer; Latifa Noussair; Anne Gigandon; Florence Espinasse; Laurent Raskine; Jérome Robert; Alain Mangeol; Catherine Branger; Jean-Claude Petit
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

6.  Chronic kidney disease as a risk factor for Clostridium difficile infection.

Authors:  Rodney Eddi; Mohammed N Malik; Rada Shakov; Walid J Baddoura; Chandra Chandran; Vincent A Debari
Journal:  Nephrology (Carlton)       Date:  2010-06       Impact factor: 2.506

7.  A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.

Authors:  Sophia V Kazakova; Kim Ware; Brittany Baughman; Oleg Bilukha; Anne Paradis; Stephen Sears; Angie Thompson; Bette Jensen; Lois Wiggs; Jemelie Bessette; James Martin; Judy Clukey; Kathleen Gensheimer; George Killgore; L Clifford McDonald
Journal:  Arch Intern Med       Date:  2006 Dec 11-25

8.  Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea.

Authors:  Chetana Vaishnavi; Babu Ram Thapa; Kandavel Thennarasu; Kartar Singh
Journal:  Indian J Pathol Microbiol       Date:  2002-01       Impact factor: 0.740

9.  Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.

Authors:  F Barbut; P Mastrantonio; M Delmée; J Brazier; E Kuijper; I Poxton
Journal:  Clin Microbiol Infect       Date:  2007-09-11       Impact factor: 8.067

10.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

View more
  17 in total

1.  A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria.

Authors:  Luigi Segagni Lusignani; Alexander Blacky; Peter Starzengruber; Magda Diab-Elschahawi; Thomas Wrba; Elisabeth Presterl
Journal:  Wien Klin Wochenschr       Date:  2016-01-27       Impact factor: 1.704

2.  Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection.

Authors:  D N Shah; N S Bhatt; J K Welch; H L Koo; K W Garey
Journal:  J Hosp Infect       Date:  2013-02-20       Impact factor: 3.926

3.  Clostridium Difficile Associated Disease: Burden of and Predictors for in Hospital Fatal Outcome. Results of a Hospital-Based Study, Bucharest, Romania.

Authors:  Niculae Ion Nedelcu; Petre Iacob Calistru; Emanoil Ceausu
Journal:  Maedica (Buchar)       Date:  2015-06

4.  Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.

Authors:  Peter Starzengruber; Luigi Segagni Lusignani; Thomas Wrba; Dieter Mitteregger; Alexander Indra; Wolfgang Graninger; Elisabeth Presterl; Magda Diab-Elschahawi
Journal:  Wien Klin Wochenschr       Date:  2014-06-06       Impact factor: 1.704

Review 5.  From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis.

Authors:  Alexander B Smith; Joshua Soto Ocana; Joseph P Zackular
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

6.  Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.

Authors:  Judith Maria Wenisch; Susanne Equiluz-Bruck; Marta Fudel; Ingun Reiter; Andrea Schmid; Erna Singer; Andreas Chott
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

Review 7.  Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Authors:  Lynne Vernice McFarland; Metehan Ozen; Ener Cagri Dinleyici; Shan Goh
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

8.  Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis.

Authors:  Gauree G Konijeti; Jenny Sauk; Mark G Shrime; Meera Gupta; Ashwin N Ananthakrishnan
Journal:  Clin Infect Dis       Date:  2014-03-31       Impact factor: 9.079

9.  Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population.

Authors:  C Alicino; D R Giacobbe; P Durando; D Bellina; A M DI Bella; C Paganino; V Del Bono; C Viscoli; G Icardi; A Orsi
Journal:  Epidemiol Infect       Date:  2016-05-19       Impact factor: 4.434

Review 10.  Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Stephanie Sirard; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.